$ZM

Dear Zoom Stock Fans, Mark Your Calendars for August 25

Zoom (ZM) reported Q1 FY2027 results on May 21. Revenue rose 5.5% to $1.24B, beating guidance and analysts. Non-GAAP EPS increased 8.4% to $1.55. Non-GAAP gross margin was 79.9%. Management raised FY27 revenue to $5.08B-$5.09B and EPS to $5.96-$6.0. ZM trades at 17.45x forward P/E; RBC reiterated Outperform with a $130 target.

Original reporting
Published Aug 13, 2026, 11:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 11:43 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Dear Zoom Stock Fans, Mark Your Calendars for August 25 — source image
Decision brief

The 30-second read

$ZMBullishMed
01

Why it matters

Raised FY27 revenue and non-GAAP EPS outlook, plus Q1 profitability and deferred revenue strength, are the core drivers for traders reassessing forward expectations.

02

Market read

Traders can use the raised FY27 guidance and Q2 ranges to update models, while the article’s valuation framing suggests the market may still be debating how much multiple expansion is justified.

03

What to watch

Deferred revenue growth is positive, but the article does not quantify customer concentration risk or competitive pricing pressure, which could affect forward estimates.

Relevance 7/10Novelty 6/10Timing: ahead of Aug 25 calendar date mentioned in headline, but guidance details are tied to prior May 21 earnings

Background

The piece discusses Zoom’s valuation after its Q1 FY2027 earnings and highlights upcoming timing referenced as Aug 25.

Company-level read

Ticker impact

$ZMBullishMedium confidence
Context

Zoom raised FY27 revenue and non-GAAP EPS guidance after Q1 FY2027 results, including higher deferred revenue and Q2 outlook.

Expected impact

Near-term bias remains upward if traders focus on raised FY27 guidance and deferred revenue growth; upside may be capped by valuation concerns.

Evidence & confidence

The text provides specific Q1 beats, Q2 revenue/EPS ranges, and raised full-year guidance, which are actionable for positioning. However, it is also a calendar-style framing and does not add a new post-earnings datapoint beyond what is already described.

Market effects

Signals continued demand and margin discipline in enterprise video/communications software, potentially supporting sentiment for collaboration peers.

No specific regional macro linkage beyond general tech valuation framing.

Limited; story is company-specific with no cross-border regulatory or supply-chain shock described.

Counterpoint

Despite raised guidance, churn in the Online segment rose to 3% and valuation is still a key debate, which could limit multiple expansion.

Key entities

  • Zoom

    Subject of the article, with Q1 FY2027 results and raised FY27 guidance plus Q2 outlook.

  • RBC Capital

    Reiterated Outperform and kept a $130 price target after the earnings release.

Related articles

$ZMMed

Zoom forecasts quarterly profit below estimates

Zoom Communications forecasted third-quarter profit below analysts' expectations, citing competition. Shares fell 3.8% in extended trading. The company expects revenue of $1.275B-$1.28B, below the $1.28B estimate, and adjusted profit of $1.46-$1.48 per share, below the $1.50 estimate. Second-quarter results exceeded expectations with $1.28B revenue and $1.55 adjusted profit per share.

$INTUHighAI 8/10

After-Hours Movers: INTU, SMTC, SYRE, ZM, NCNO

Intuit (INTU) fell 9% after lowering FY2027 guidance, missing EPS and revenue estimates. Semtech (SMTC) rose 3% on strong Q2 results and raised Q3 outlook. Spyre Therapeutics (SYRE) dropped 16% due to failed clinical trial results. Zoom (ZM) declined 3.5% despite Q2 beat, citing growth normalization. nCino (NCNO) fell 10% on near-term guidance concerns.

$ZMMedAI 8/10

Why is Zoom Video Communications stock sliding today?

Zoom Video Communications (ZM) stock fell 2.6% in after-hours trading despite beating fiscal Q2 2027 revenue and EPS estimates. Revenue was $1.277B vs. $1.269B expected, and EPS was $1.55 vs. $1.48. Guidance for fiscal 2027 was modestly raised but in line with expectations. Analysts' reactions were mixed, with Cantor Fitzgerald reiterating a Neutral rating and Bank of America reinstating a Buy rating. The stock had already pulled back from its intraday high of $104.93 during regular trading.